Back to Awarded Treatment Trials
Awarded Trial: 06T-776
Grant ID
06T-776
Illness
Schizophrenia
Primary Drug/Intervention
Artemether
Primary Dosage
80 mg/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Wang
Sample Size
100
Duration of Study Period for Each Subject
8 weeks
Outcome Measurements
PANSS
Results
100 individuals who had been diagnosed with schizophrenia for less than 2 years and who were seropositive for antibodies to Toxoplasma gondii were randomized to risperidone or risperidone plus artemether for 8 weeks. The individuals were assessed for changes in clinical symptoms and cognitive function. There were no differences between the groups.
Publication
N/A
Link
N/A
PI Name
Gao-Hua Wang
Degree
MD
Center
Renhim Hospital
Institution
Wuhan University
Address
238 Jiefang Road, Wuchang
City or Town
Wuhan
State or Province
Hubei
Zip or Postal Code
430060
Country
China
Email Address
wanggaohuad@tom.com